Site records / Karnataka / FEI 3019975128

Auriga Research Private LimitedBengaluru, Karnataka

FDA-registered drug establishment in Bengaluru, Karnataka: analysis. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.

Inspections posted: 1
Last inspection: Feb 2026 · OAI
Warning letters to this FEI: 1
Import alerts at this address: 0
US border refusals, 2 years: 0

The site dossier

This site, graded.
Every fact sourced.

A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
Warning-letter violations, numbered and labelled
Import-alert history rebuilt from the archive, each listing checked against this address
Border refusals by product, and the company's other sites, each graded
A hash of every source read, so the PDF can be checked against the record

On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.

PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.

By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.

Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan

Inspections

1 FDA inspection of this FEI, by end date; 1 with a posted classification.

6 Feb 2026OAI · Official Action IndicatedDrug Quality Assurance · 3 citations posted

Warning letters and compliance actions

12 Aug 2026Warning Letter · CDER SourceCGMP/Finished Pharmaceuticals/Adulterated

Import alerts in force

No listing in force under this firm's name.

Registration

FEI: 3019975128
DUNS: 854154097
Registered as: Auriga Research Private Limited
Registrant: Auriga Research Private Limited
Address: Plot No. 136, 6th Cross, 2nd Stage, Yeshwanthpur Industrial Suburb, Bengaluru, Karnataka 560022, India (IND)
Operations: ANALYSIS
Registration expires: 31 Dec 2026

Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.